Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Product: Cervarix
Active Ingredients: Human Papillomavirus (HPV) 16 L1 Protein 20µg
Human Papillomavirus (HPV) 18 L1 Protein 20µg
Dosage Form: Suspension for injection
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturers: GlaxoSmithKline Biologicals SA, Parc de la Noire Epine, Wavre, Belgium
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Product: Emend IV
Active Ingredient: Fosaprepitant dimeglumine 40mg/mL
Dosage Form: Powder for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: DSM Pharmaceuticals Inc, Greenville, North Carolina, United States of America
Product: Lamivudine
Active Ingredient: Lamivudine 10mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Salcette, Goa, India
Product: Oxytrol
Active Ingredient: Oxybutynin 36mg
Dosage Form: Transdermal patch
New Zealand Sponsor: Hospira NZ Limited
Manufacturer: Watson Pharmaceuticals Inc., Salt Lake City, Utah, United States of America
Dated this 18th day of January 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).